SRC and STAT3 signaling enhances the transcription of angiogenic genes (e.g., IL8, VEGF) in human pancreatic cancer cells [56–58], while inhibition of SRC activity decreases STAT3 phosphorylation and tumorigenicity [56]. The gene discussed is STAT3; the disease is familial pancreatic carcinoma.